Pemphigus foliaceus associated with cilazapril

Buzon, E.; Perez-Bernal, A.M.; de la Pena, F.; Rios, J.J.; Camacho, F.
June 1998
Acta Dermato-Venereologica;6/1/1998, Vol. 78 Issue 3, p227
Academic Journal
Examines the occurrence of pemphigus after using cilazapril, a non-thiol-containing angiotensin-converting enzyme (ACE) inhibitor. Definition of pemphigus; Performance of skin biopsy; Use of oral prednisone as treatment.


Related Articles

  • Importância do cirurgião-dentista no diagnóstico precoce do pênfigo vulgar. Santos, Thiago de Santana; Piva, Marta Rabello; Kumar, Paulo Nand; Martins Filho, Paulo Ricardo Saquete; Reinheimer, Daniele Machado; Acevedo, Carla Renata // RGO: Revista Gaúcha de Odontologia;jul-set2009, Vol. 57 Issue 3, p351 

    The vulgar pemphigus is a chronic, rare, vesicle-bubble disease of autoimmune origin and with a possibility of following a dangerous clinical course when it is not diagnosed and treated in its initial stage. It usually affects people from 40 to 60 years old, being rare in children. In the...

  • An infrequent cause of chronic cough. Respicio, Guada // Clinical Advisor;Feb2010, Vol. 13 Issue 2, p113 

    The article presents a case study of a 54-year old woman who complained of a cough for five years and was progressively worsening. When she was examined, her surgical history was negative, but her medical history included hypertension and osteopenia. The result of her lung biopsy showed that she...

  • Vesiculobullous eruptions. CHAN, STANLEY // Clinical Advisor;Jan2010, Vol. 13 Issue 1, p69 

    The article presents two case studies on vesiculobullous eruptions specifically on the diagnosis and treatment of pemphigus vulgaris (PV) and bullous pemphigoid (BP) among the Caucasian race in the U.S. PV patients are recommended to take prednisone and azathioprine to be able to improve the...

  • Eosinophilic Sclerosing Cholangitis Associated with Hypereosinophilic Syndrome. Grauer, Leopoldo; Padilla, Victor M.; Bouza, Lazaro; Barkin, Jamie S. // American Journal of Gastroenterology;Oct1993, Vol. 88 Issue 10, p1764 

    We describe the case of a 41-yr-old man who presented with signs and symptoms of cholestasis including abdominal pain, jaundice, and fever, with peripheral eosinophilia of 10% and bone marrow eosinophilia. Liver biopsy revealed an eosinophilia infiltrate and an ERCP demonstrated bile duct...

  • Levofloxacin interaction.  // Reactions Weekly;7/23/2005, Issue 1061, p12 

    Presents a case study of an interaction with concomitant paracetamol, caffeine, salicylamide, promethazine leading to fixed drug eruption in an 80-year-old woman. Development of a fixed drug eruption associated with the concomitant administration of levofloxacin and an over-the-counter cold...

  • Nephrotic Syndrome in a Patient with Ulcerative Colitis and Colonic Carcinoma. Caruana, Ralph J.; Griffin Jr., Joseph W. // American Journal of Gastroenterology;Dec1980, Vol. 74 Issue 6, p525 

    A 27-year old man with a long history of ulcerative colitis developed a nephrotic syndrome. Renal biopsy revealed a minimal change lesion and further evaluation revealed that the patient had colonic carcinoma. Total colectomy and a course of prednisone were followed by a complete and lasting...

  • Level of Renal Impairment Does Not Affect Pharmacokinetics of Irbesartan.  // Kidney;Nov/Dec98, Vol. 7 Issue 6, p272 

    Presents an abstract of the study 'Level of Renal Impairment Does Not Affect Pharmacokinetics of Irbesartan,' by D.S. Sica et al published in a 1997 issue of the 'Clinical Pharmacology and Therapeutics.'

  • Saving lives after myocardial infarction.  // Modern Medicine;Dec95, Vol. 63 Issue 12, p25 

    Reports on four studies that concluded that ACE (angiotensin-converting enzyme) inhibitors when given within 24 hours of a myocardial infarction can save the person's life.

  • Clinical Pharmacokinetics of Candesartan. Gleiter, C.H.; Mörike, K.E. // Clinical Pharmacokinetics;Jan2002, Vol. 41 Issue 1, p7 

    Candesartan cilexetil is the prodrug of candesartan, an angiotensin II type 1 (AT) receptor antagonist. Absorbed candesartan cilexetil is completely metabolised to candesartan. Oral bioavailability is low (about 40%) because of incomplete absorption. Plasma protein binding in humans is more than...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics